Details of the Drug Formulations

General Information of Drug (ID: DMKMBES)

• Drug Name: Plazomicin Drug Info
• Synonyms: ACHN-490; UNII-LYO9XZ250J; 1154757-24-0; LYO9XZ250J; Plazomicin [USAN:INN]; Plazomicin (USAN); ZINC68150640; DB12615; D10151; D-Streptamine,

Indication

Disease Entry	ICD 11	Status	REF
Bronchitis	CA20	Approved	[1]
Prostate disease	GA91	Approved	[1]
Urinary tract infection	GC08	Approved	[1]
Pancreatic cancer	2C10	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 42613186
  CAS Number: 1154757-24-0
  TTD ID: D0E6BB
  INTEDE ID: DR2136
  ACDINA ID: D01346

Full List of Drug Formulations Containing This Drug

Plazomicin 500 mg/10 ml Injection

Company	Formulation ID	FDA Description
Cipla Usa	F23258	Water; Sodium Hydroxide

References

• [1] In vitro activity of plazomicin against -lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).J Antimicrob Chemother. 2017 Oct 1;72(10):2792-2795.
• [2] ClinicalTrials.gov (NCT01970371) A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE). U.S. National Institutes of Health.